by Admin | Mar 23, 2026 | News
FDA says it is requesting that drug application holders remove information regarding suicidal ideation and behavior from the labeling of certain GLP-1 receptor agonist medications, specifically Saxenda, Wegovy, and Zepbound. The agency says this follows a...
by Admin | Mar 22, 2026 | News
FDA says it is requiring application holders for all drug products containing carbidopa/levodopa to add a warning that these medicines can cause vitamin B6 deficiency and vitamin B6 deficiency-associated seizures. The agency says the products are approved to treat...
by Admin | Mar 18, 2026 | Careers, News
A growing wave of concern is emerging across parts of the pharmaceutical and drug safety industry over alleged proxy interviews, false professional representation, and unethical third-party involvement in pharmacovigilance hiring. Across regulated safety functions,...
by Admin | Mar 14, 2026 | News
MHRA has published a Class 3 Medicines Recall for Bayer Plc, various products, EL(26)A/12. The agency said Bayer is recalling all stock of the listed products as a precautionary measure because an impurity above the acceptable limit was identified. MHRA said the...
